banner

Basın Bülteni

Press Room

First in Europe Turgut Pharmaceuticals

First in Europe Turgut Pharmaceuticals

The SR4SB Project, run by Turgut İlaçları A.Ş., was selected as the European First in the 2022 EURIPIDES² Innovation Awards.

That First Day's Vision, Today's Righteous Pride

That First Day's Vision, Today's Righteous Pride

The Biopharmaceutical facility established by Turgut Pharmaceuticals in Gebze, which developed and produced Turkey's first end-to-end Biosimilar Monoclonal Antibody and completed its Phase 1 study, received the TITCK Approved GMP Certificate.

Turgut Pharmaceuticals, a pioneer in its sector

Turgut Pharmaceuticals, a pioneer in its sector

Turgut Pharmaceuticals continues to draw attention with its success in the health sector and its pioneering position against its competitors.